Clinical Kidney Journal - November 2023

Check out the new November issue of CKJ, fully open access!

Content:

The optimized anticoagulation strategy in prolonged hemodialysis
The results of this study indicate that there is no need to administer enoxaparin over two injections for ENHD up to 8 h. The usefulness of monitoring anti-Xa levels to predict fiber patency, assessed by µCT, can be questioned, but further clinical trials are needed.

Ultraprocessed foods and chronic kidney disease—double trouble
In this Review the authors discuss the potential risk of UPFs in activating hedonic eating and their main implications for health, especially for kidney health and metabolic complications of CKD.

Personalizing electrolytes in the dialysis prescription: what, why and how?
­This Review discusses how the treatment of maintenance hemodialysis patients could benefit from individualized changes in certain dialysis fluid components.

Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease
­This comprehensive Review suggests that Klotho could open the door to novel interventions aimed at addressing the challenges of aging and neurodegenerative disorders.

Read more